…and commercial viability by scaling-up and validating manufacturing, confirming their regulatory path and clinical trial plans, and establishing commercial partnerships. Dental, Oral, & Craniofacial Tissues Targeted by ITPs C-DOCTOR aims…
…and securing NIH funding. His commitment to improving patient care through regenerative medicine and tissue engineering drives the success of C-DOCTOR. Michael Jamieson, DRsc Core Resource Director Michael Jamieson, DRsc…
…a highly competitive opportunity for promising regenerative medicine projects that accelerate completion of translational stage activities necessary for advancement to clinical study. Hydronovo’s product will advance CIRM’s mission to accelerate…
…development strategy The four points listed here are critical, but if you still have questions please feel free to reach out to us. Can the proposed project be testing an…
C-DOCTOR Vision The Center for Dental, Oral, & Craniofacial Tissue & Organ Regeneration (C-DOCTOR) is a comprehensive national resource center (RC) for the clinical translation of innovative regenerative technologies to…
…kinase inhibitor hydrogel Indication: Prevent hypertrophic scar formation from burn and trauma wounds Regulatory strategy: IND – Combination product with the drug being the Primary Mode of Action Click here…
…to oral and systemic health. The award letter notes Chai’s “outstanding national and international contributions to teaching and research in oral health science.” Click here to read more: https://dentistry.usc.edu/university-professor-yang-chai-wins-2023-harvard-school-of-dental-medicines-paul-goldhaber-award/ https://www.thecrimson.com/article/2023/10/18/yang-chai-goldhaber-award/…
C-DOCTOR PI Dr. Michael Longaker publishes “Exploring the Overlooked Roles and Mechanisms of Fibroblasts in the Foreign Body Response” in “Advances in wound care”. Click here to read more: https://www.liebertpub.com/doi/epub/10.1089/wound.2022.0066…
…Radiation-Injured Skin)!” Their team filed the IND application on November 30, 2023, and received their “study may proceed” letter on January 3, 2024, allowing them to begin their clinical trial….
The Hydronovo ITP team publishes “Long-term functional regeneration of radiation-damaged salivary glands through delivery of a neurogenic hydrogel” in Science Advances. Click here to read more: https://www.science.org/doi/10.1126/sciadv.adc8753?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Click here to…